Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration

Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration

Cardiovascular diseases (CVDs) represent a significant global health burden, demanding innovative therapeutic approaches. In recent years, mRNA therapeutics have emerged as a promising strategy to combat CVDs effectively. Unlike conventional small-molecule drugs, mRNA therapeutics enable the direct...

Full description

Bibliographic Details
Main Authors:	Raj Kishore, Ajit Magadum
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Journal of Cardiovascular Development and Disease
Subjects:	gene therapy cardiovascular disease mRNA therapeutics modRNA heart failure lipid nanoparticles
Online Access:	https://www.mdpi.com/2308-3425/11/2/38

Similar Items

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
by: Magdalena M. Żak, et al.
Published: (2021-10-01)

Modified mRNA Therapeutics for Heart Diseases
by: Ajit Magadum
Published: (2022-12-01)

mRNA in the Context of Protein Replacement Therapy
by: Theofanis Vavilis, et al.
Published: (2023-01-01)

Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers
by: Huijing Wang, et al.
Published: (2023-01-01)

Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?
by: Lucia La Sala, et al.
Published: (2024-03-01)

Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform
by: Luca Roncati, et al.
Published: (2024-01-01)

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
by: Maryam Youssef, et al.
Published: (2023-10-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01)

Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
by: Tahir Haideri, et al.
Published: (2022-09-01)

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
by: Yu-Shiuan Wang, et al.
Published: (2023-10-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01)

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022-02-01)

Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01)

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
by: Owen Daly, et al.
Published: (2023-06-01)

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01)

Ionizable Lipid Nanoparticles for mRNA Delivery
by: Xuefeng Tang, et al.
Published: (2023-08-01)

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
by: Karol Kurpiejewski, et al.
Published: (2024-02-01)

Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics
by: Wei Yang, et al.
Published: (2023-05-01)

Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity
by: Denise A Warzak, et al.
Published: (2023-10-01)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
by: Kun Zhou, et al.
Published: (2023-07-01)

A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn–Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year
by: Luca Roncati, et al.
Published: (2024-02-01)

A Comprehensive Review of mRNA Vaccines
by: Vrinda Gote, et al.
Published: (2023-01-01)

mRNA vaccines in the prevention and treatment of diseases
by: Yangzhuo Gu, et al.
Published: (2022-09-01)

From structural design to delivery: mRNA therapeutics for cancer immunotherapy
by: Feng Zhou, et al.
Published: (2024-04-01)

Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions
by: Muhammad Nawaz, et al.
Published: (2023-04-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023-04-01)

Modeling the effect of rRNA-mRNA interactions and mRNA folding on mRNA translation in chloroplasts
by: Stav Carmel Ezra, et al.
Published: (2022-01-01)

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
by: Emma N. Welbourne, et al.
Published: (2024-03-01)

Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity
by: Lin Wang, et al.
Published: (2023-12-01)

mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01)

mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
by: Andreas Ouranidis, et al.
Published: (2021-12-01)

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
by: Gonna Somu Naidu, et al.
Published: (2023-07-01)

Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
by: Tongren Yang, et al.
Published: (2020-12-01)

Application of mRNA Technology in Cancer Therapeutics
by: Yesim Eralp
Published: (2022-08-01)

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments
by: Hairui Zhang, et al.
Published: (2020-10-01)

Virus Infection and mRNA Nuclear Export
by: Jiayin Guo, et al.
Published: (2023-08-01)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
by: De‐feng Li, et al.
Published: (2023-05-01)

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
by: Wei Liu, et al.
Published: (2022-11-01)

Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination
by: Luca Roncati, et al.
Published: (2022-04-01)